Bipolar Disorders Treatment Companies

ID: MRFR/Pharma/1037-HCR

200 Pages

Nidhi Mandole

Last Updated: February 16, 2025

Bipolar disorder is a mental health condition characterized by extreme mood swings, encompassing episodes of mania and depression. The management and treatment of bipolar disorders require a multidimensional approach, combining medication, psychotherapy, and lifestyle adjustments.

Bipolar Disorders Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.7%

2024 Market Size$ 4.62 Billion

2025 Market Size$ 4.88 Billion

2035 Market Size$ 8.5 Billion

Key Players

Eli Lilly and Company

Johnson & Johnson

Pfizer Inc.

AstraZeneca PLC

Bristol-Myers Squibb Company

GlaxoSmithKline PLC

Trends

Rise of Personalized Medicine
Integration of Digital Health Solutions
Focus on Early Intervention Strategies

Opportunities

Growing Acceptance of Telemedicine
Emphasis on Holistic Treatment Approaches
Advancements in Pharmacological Treatments

Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Bipolar Disorders Treatment Market

Bipolar Disorders Treatment Key Companies

Latest Bipolar Disorders Treatment Companies Update:

Alkermes Received US FDA approval for LYBALVITM (olanzapine and samidorphan), the first combination medication specifically approved for the treatment of bipolar I disorder.

Johnson & Johnson Acquired Spindrift Pharmaceuticals, a company developing novel gene therapy treatments for bipolar disorder and other neurological conditions.

Evidation Health Launched a digital health platform for bipolar disorder management, providing personalized insights and support to patients and their caregivers.

Mindstrong Health Received funding from GV (formerly Google Ventures) to expand its virtual therapy platform for mental health conditions, including bipolar disorder.

Sage Therapeutics Presented positive Phase 3 trial results for zuranolone, a novel neuroactive steroid medication, in the treatment of bipolar depression.

List of Bipolar Disorders Treatment Key companies in the market

Allergan
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Abbott
Bristol-Myers Squibb
Johnson & Johnson
Pfizer Inc.
Cephalon Inc.
Otsuka America Pharmaceutical Inc.
Gedeon Richter plc

Customize Report

Certified Researchers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Bipolar Disorders Treatment Companies

Top Industry Leaders in the Bipolar Disorders Treatment Market

Related Reports

Customer Stories